Emergent BioSolutions, Inc. (EBS)
6.33
-0.04
(-0.63%)
USD |
NYSE |
Oct 02, 16:00
6.335
0.00 (0.00%)
Pre-Market: 20:00
Emergent BioSolutions Profit Margin (Quarterly) : -76.91% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -76.91% |
| March 31, 2026 | 4.36% |
| December 31, 2025 | -36.72% |
| September 30, 2025 | 22.15% |
| June 30, 2025 | -8.52% |
| March 31, 2025 | 30.60% |
| December 31, 2024 | -16.08% |
| September 30, 2024 | 39.07% |
| June 30, 2024 | -111.2% |
| March 31, 2024 | 3.00% |
| December 31, 2023 | -17.90% |
| September 30, 2023 | -97.38% |
| June 30, 2023 | -77.33% |
| March 31, 2023 | -113.3% |
| December 31, 2022 | -26.61% |
| September 30, 2022 | -36.31% |
| June 30, 2022 | -23.24% |
| March 31, 2022 | -1.20% |
| December 31, 2021 | 26.18% |
| September 30, 2021 | -9.94% |
| June 30, 2021 | 1.16% |
| March 31, 2021 | 20.32% |
| December 31, 2020 | 31.80% |
| September 30, 2020 | 10.25% |
| June 30, 2020 | 23.49% |
| Date | Value |
|---|---|
| March 31, 2020 | -6.49% |
| December 31, 2019 | 13.01% |
| September 30, 2019 | 13.86% |
| June 30, 2019 | -3.91% |
| March 31, 2019 | -13.64% |
| December 31, 2018 | -1.26% |
| September 30, 2018 | 12.06% |
| June 30, 2018 | 22.77% |
| March 31, 2018 | -4.17% |
| December 31, 2017 | 17.51% |
| September 30, 2017 | 22.45% |
| June 30, 2017 | 4.58% |
| March 31, 2017 | 8.97% |
| December 31, 2016 | 21.29% |
| September 30, 2016 | 14.27% |
| June 30, 2016 | -2.24% |
| March 31, 2016 | 11.55% |
| December 31, 2015 | 26.59% |
| September 30, 2015 | 26.57% |
| June 30, 2015 | 11.18% |
| March 31, 2015 | -33.82% |
| December 31, 2014 | 20.35% |
| September 30, 2014 | 15.83% |
| June 30, 2014 | 4.56% |
| March 31, 2014 | -37.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Exelixis, Inc. | 33.73% |
| Capricor Therapeutics, Inc. | -- |
| ADMA Biologics, Inc. | 30.40% |
| Akebia Therapeutics, Inc. | -18.13% |
| Arcutis Biotherapeutics, Inc. | 11.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.28% |
| Return on Assets | -13.30% |
| Return on Invested Capital | -15.62% |
| Gross Profit Margin (Quarterly) | 51.22% |
| Operating Margin (Quarterly) | 28.25% |
| Return on Net Operating Assets | -16.25% |